Clinical Trial Update: Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating medroxyprogesterone acetate plus atorvastatin in young women with atypical endometrial hyperplasia or early-stage endometrial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Carcinoma

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I | Phase 2 | Status: RECRUITING